21.51
price down icon3.54%   -0.79
after-market Dopo l'orario di chiusura: 21.51
loading

Neurogene Inc Azioni (NGNE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
8.75%
23.80
26.08 25.92 21.51 22.18
Operating Income/Loss
8.75%
-23.80
-26.08 -25.92 -21.51 -22.18
Income/Loss From Continuing Operations Before Tax
4.83%
-20.95
-22.02 -22.65 -76.07 -20.22
Income/Loss From Continuing Operations After Tax
4.83%
-20.95
-22.02 -22.65 -19.51 -20.22
Net Income/Loss
4.83%
-20.95
-22.02 -22.65 -19.51 -20.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.54%
21.17
21.06 21.00 0.6341 16.95
Diluted Average Shares
0.54%
21.17
21.06 21.00 0.6341 16.95
Basic Earnings Per Share
5.71%
-0.99
-1.05 -1.08 -0.99 -1.19
Diluted Earnings Per Share
5.71%
-0.99
-1.05 -1.08 -0.99 -1.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):